Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
07/26/2001 | US20010009667 Method of detecting nucleic acid encoding a retrovirus using polymerase chain reaction (pcr) |
07/26/2001 | DE19960225A1 Raum- oder Kristallform mindestens eines Polypeptids pro asymmetrischer Einheit, enthaltend mindestens eine an der Katalyse beteiligte (Sub)-Domäne eines Calpains Spatial or crystal form of at least one polypeptide per asymmetric unit containing at least one involved in catalysis (sub) domain of calpain |
07/26/2001 | DE19953167A1 Mit TRP-Proteinen verwandtes Protein MTR1 und dieses codierende DNA-Sequenz With TRP proteins related protein MTR1 and this DNA sequence encoding |
07/26/2001 | DE10002920A1 Device for contacting biological material immobilized on surface with solution of second biological material, especially hybridization of DNA samples, comprises a cavity receiving solution with cover which has seal around its edges |
07/26/2001 | DE10001975A1 Non-human mammal with altered inducing functions for the glucocorticoid receptor, useful for testing e.g. therapeutic agents, also has altered c-Fos activity |
07/26/2001 | DE10000978A1 Verfahren zur Erhöhung des Gehalts an Fettsäuren in Pflanzen und Mikroorganismen A process for increasing the content of fatty acids in plants and microorganisms |
07/26/2001 | DE10000651A1 Identifying inhibitors and activators of eukaryotic potassium channels, for use as pharmaceuticals, comprises using yeast cells that express heterologous, but no endogenous, potassium channels |
07/26/2001 | CA2479511A1 Compositions and methods for the treatment of tumor |
07/26/2001 | CA2479498A1 Compositions and methods for the treatment of tumor |
07/26/2001 | CA2436918A1 Methods for amplifying genetic material and uses thereof |
07/26/2001 | CA2412536A1 Method for isolating proteins or protein and nucleic acid associations, and resulting complexes of particles and proteins, reagents and applications |
07/26/2001 | CA2402831A1 Prime-boost vaccination strategy |
07/26/2001 | CA2401786A1 Contacting device |
07/26/2001 | CA2398842A1 Replication deficient adenovirus vectors |
07/26/2001 | CA2398710A1 Egg specific surface proteins |
07/26/2001 | CA2398695A1 Chondromodulin-i related peptide |
07/26/2001 | CA2398690A1 Barcoded synthetic lethal screening to identify drug targets |
07/26/2001 | CA2398605A1 Methods for the purification and aqueous fiber spinning of spider silks and other structural proteins |
07/26/2001 | CA2398343A1 Virus strains for the oncolytic treatment of cancer |
07/26/2001 | CA2398239A1 Multipotent neural stem cells from peripheral tissues and uses thereof |
07/26/2001 | CA2398237A1 Manufacture of five-carbon sugars and sugar alcohols |
07/26/2001 | CA2398083A1 Nphs2 gene involved in the cortico-resistant neprhotic syndrome, protein encoded by said gene and diagnostic and therapeutic uses |
07/26/2001 | CA2398058A1 Gene chip for neonate screening |
07/26/2001 | CA2398010A1 An in vivo screen using chemical inducers of dimerization |
07/26/2001 | CA2397946A1 Lipid metabolism enzymes |
07/26/2001 | CA2397927A1 Liver tissue source |
07/26/2001 | CA2397919A1 Pharmaceutical compositions and methods of treatment based on vegf antisense oligonucleotides |
07/26/2001 | CA2397904A1 Wt1 interacting protein wtip |
07/26/2001 | CA2397903A1 Use of paramyxovirus vector for gene transfer into blood vessel |
07/26/2001 | CA2397901A1 Cbp86, a sperm specific protein |
07/26/2001 | CA2397896A1 Human sperm specific lysozyme-like proteins |
07/26/2001 | CA2397838A1 Sperm specific proteins |
07/26/2001 | CA2397833A1 Novel haptotactic peptides |
07/26/2001 | CA2397783A1 Human gaba receptor proteins and polynucleotides encoding the same |
07/26/2001 | CA2397774A1 Jak/stat pathway inhibitors and the uses thereof |
07/26/2001 | CA2397617A1 Novel human nucleic acid molecules and polypeptides encoding cation channels |
07/26/2001 | CA2397598A1 Combinations for treating neoplasms |
07/26/2001 | CA2397571A1 Apoptin-associating protein |
07/26/2001 | CA2397562A1 Flavobacterium heparinum expression system |
07/26/2001 | CA2397492A1 Method for nucleic acid transfection of cells |
07/26/2001 | CA2397324A1 Genes encoding abc1 paralogs and the polypeptides derived therefrom |
07/26/2001 | CA2397205A1 Antisense modulation of macrophage migration inhibitory factor expression |
07/26/2001 | CA2397202A1 Antisense modulation of glycogen synthase kinase 3 alpha expression |
07/26/2001 | CA2396969A1 Transgenic goat producing milk containing human granulocyte-colony stimulating factor |
07/26/2001 | CA2396935A1 Phosphatases |
07/26/2001 | CA2396898A1 Methods and compositions to modulate expression in plants |
07/26/2001 | CA2396810A1 Sensitive, multiplexed diagnostic assays for protein analysis |
07/26/2001 | CA2396697A1 Antisense modulation of glycogen synthase kinase 3 beta expression |
07/26/2001 | CA2396283A1 Human cystine knot polypeptide |
07/26/2001 | CA2396212A1 Recombinant antibodies to human interleukin-1 beta |
07/26/2001 | CA2395855A1 Recombinant flaviviruses and methods of use thereof |
07/26/2001 | CA2395770A1 Methods and materials relating to novel von willebrand/thrombospondin-like polypeptides and polynucleotides |
07/26/2001 | CA2395763A1 Methods and materials relating to semaphorin-like polypeptides and polynucleotides |
07/26/2001 | CA2395749A1 Methods and materials relating to prothrombinase-like polypeptides and polynucleotides |
07/26/2001 | CA2395736A1 Novel nucleic acids and polypeptides |
07/26/2001 | CA2395731A1 Methods and materials relating to g protein-coupled receptor-like polypeptides and polynucleotides |
07/26/2001 | CA2395054A1 Human polynucleotides, polypeptides, and antibodies |
07/26/2001 | CA2394753A1 Human protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies |
07/26/2001 | CA2390819A1 Novel root-preferred promoter elements and methods of use |
07/26/2001 | CA2390753A1 Novel plant promoters and methods of use |
07/26/2001 | CA2365610A1 Compositions and methods for the treatment of tumor |
07/26/2001 | CA2362767A1 Regeneration and genetic transformation of acacia mangium |
07/25/2001 | EP1118858A2 Assay method |
07/25/2001 | EP1118681A1 Method for controlling the release of granules |
07/25/2001 | EP1118680A1 Method for the diagnosis of polymorphisms in the human PDH E1alpha gene |
07/25/2001 | EP1118679A1 Method for diagnosing polymorphisms in the human PDH E2 gene |
07/25/2001 | EP1118678A1 Method for diagnosing polymorphisms in the human PDH E1 beta gene |
07/25/2001 | EP1118676A2 Cell isolation method |
07/25/2001 | EP1118670A1 Canine adenovirus vectors for the transfer of genes in targeted cells |
07/25/2001 | EP1118669A2 Production of camelid antibodies in plants |
07/25/2001 | EP1118667A1 Novel enzyme compositions, process for producing the same and utilization of the same |
07/25/2001 | EP1118666A2 Nucleotide sequences coding for the Corynebacterium glutamicum ptsH gene |
07/25/2001 | EP1118665A1 Recombinant production of aromatic polyketides |
07/25/2001 | EP1118664A1 Established cells |
07/25/2001 | EP1118663A1 Nucleic acids encoding chemotaxis inhibitory polypeptides |
07/25/2001 | EP1118662A2 Apoptin-associating protein |
07/25/2001 | EP1118661A1 T cell receptor libraries |
07/25/2001 | EP1118660A1 Enzyme producing plasma protein fragment having effect of inhibiting cancer metastasis and plasma protein fragment fragmented by the enzyme |
07/25/2001 | EP1118659A1 Expression systems for functional nucleic acid expression |
07/25/2001 | EP1118658A1 METHOD FOR PREPARING HIGH PERFORMANCE RecA-LIKE RECOMBINASE/SINGLE-STRANDED NUCLEIC ACID PROBE COMPLEX AND UTILIZATION THEREOF |
07/25/2001 | EP1118621A1 Novel g protein-coupled receptor protein and dna thereof |
07/25/2001 | EP1118620A1 Novel g protein-coupled receptor protein and dna thereof |
07/25/2001 | EP1117996A2 Method and device for producing and/or analyzing biochemical reaction supporting materials |
07/25/2001 | EP1117843A1 An in vitro activity assay for human hepatitis b virus - (hbv) dna polymerase, and its use for screening for inhibitors of hbv dna polymerase |
07/25/2001 | EP1117840A1 Methods for treating or identifying a subject at risk for a neurological disease by determining the presence of a variant gpiiia and/or variant gpiib allele |
07/25/2001 | EP1117838A1 A method for analyzing polynucleotides |
07/25/2001 | EP1117836A2 Expressionanalysis of specific nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
07/25/2001 | EP1117835A1 Prevention of adhesions |
07/25/2001 | EP1117834A1 Multiplex genotyping using fluorescent hybridization probes |
07/25/2001 | EP1117833A1 A novel method of diagnosing, monitoring, staging, imaging and treating gastrointestinal cancers |
07/25/2001 | EP1117832A1 Detection of nucleic acid polymorphism |
07/25/2001 | EP1117831A1 Method for dna- or rna-sequencing |
07/25/2001 | EP1117830A1 Method for determining transcription factor activity and its technical uses |
07/25/2001 | EP1117829A1 Susceptibility locus for osteoarthritis |
07/25/2001 | EP1117828A1 Susceptibility locus for osteoarthritis |
07/25/2001 | EP1117827A1 Methods of nucleic acid amplification and sequencing |
07/25/2001 | EP1117826A1 Oligonucleotide primers that destabilize non-specific duplex formation and uses thereof |
07/25/2001 | EP1117824A1 Use of s-ydcb and b-ydcb, essential bacterial genes |
07/25/2001 | EP1117819A1 Plants and plant cells encoding the wildtype cop1 gene and the coil domain thereof |
07/25/2001 | EP1117818A2 Maize promoters |